MedPath

TEVA-TEMOZOLOMIDE

TEVA-TEMOZOLOMIDE

Approved
DIN Number

02395274

Drug Class

Human

Market Date

Nov 7, 2012

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02395274
AIG Number0138781002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01AX03 TEMOZOLOMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TEMOZOLOMIDEActive
Strength: 20 MG
Monograph: TEMOZOLOMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.